BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Endothelial cell
,
Nosology
,
Ciprofibrate
,
rs2300478
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukin 2
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IL2RA
TSC22D3
DUSP1
GZMB
EGR1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PUJANA_BRCA1_PCC_NETWORK
LEE_BMP2_TARGETS_DN
DODD_NASOPHARYNGEAL_CARCINOMA_DN
FISCHER_DREAM_TARGETS
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Progesterone-regulated genes in immune cells: Regulation of T cell genes by progesterone
Differentiation of naïve B cells into memory B cells and plasma cells
B cell differentiation series through plasmablast stage to antibody secreting plasma cell
T regulatory and T effector cells CD3/CD28 stimulation timecourse analysis
CD4+ T cells from miR-155 knockout and wildtype mice activated in vitro for 3d
Explore Curated Studies Results
Literature
Most Relevant Literature
Location, location, location! Rewiring IL-2 circuits defines context-specific outcomes.
Bempeg Failure Unlikely to Affect Other IL2 Drugs.
Therapeutic potential of interleukin-2 in autoimmune diseases.
An IL-2 Protein Therapeutic for Cancer that Gains Function on the Spot.
Interleukin-2 and regulatory T cells in rheumatic diseases.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HIV Reservoir Reduction With Interleukin-2
Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria
Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ